Nurix Therapeutics, Inc. Quarterly Common Stock, Shares, Issued from Q4 2019 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Nurix Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2019 to Q3 2024.
  • Nurix Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending August 31, 2024 was 67.1M shares, a 38.3% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 67.1M +18.6M +38.3% Aug 31, 2024 10-Q 2024-10-11
Q2 2024 64.4M +16.7M +35.1% May 31, 2024 10-Q 2024-07-11
Q1 2024 49.1M +1.69M +3.57% Feb 29, 2024 10-Q 2024-04-10
Q4 2023 48.7M +1.55M +3.28% Nov 30, 2023 10-Q 2024-10-11
Q3 2023 48.5M +1.36M +2.88% Aug 31, 2023 10-Q 2023-10-12
Q2 2023 47.6M +2.59M +5.75% May 31, 2023 10-Q 2023-07-13
Q1 2023 47.4M +2.59M +5.78% Feb 28, 2023 10-Q 2023-04-13
Q4 2022 47.2M +2.51M +5.62% Nov 30, 2022 10-K 2024-02-15
Q3 2022 47.1M +2.59M +5.82% Aug 31, 2022 10-Q 2022-10-06
Q2 2022 45M +637K +1.43% May 31, 2022 10-Q 2022-07-07
Q1 2022 44.9M +5.73M +14.7% Feb 28, 2022 10-Q 2022-04-08
Q4 2021 44.7M +5.8M +14.9% Nov 30, 2021 10-K 2023-02-09
Q3 2021 44.6M +5.71M +14.7% Aug 31, 2021 10-Q 2021-10-14
Q2 2021 44.4M May 31, 2021 10-Q 2021-07-13
Q1 2021 39.1M Feb 28, 2021 10-Q 2021-04-13
Q4 2020 38.9M +35.3M +981% Nov 30, 2020 10-K 2022-01-28
Q3 2020 38.8M Aug 31, 2020 10-Q 2020-10-14
Q4 2019 3.6M Nov 30, 2019 10-K 2021-02-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.